Literature DB >> 20042633

Computational analysis identifies human adenovirus type 55 as a re-emergent acute respiratory disease pathogen.

Michael P Walsh1, Jason Seto, Morris S Jones, James Chodosh, Wenbo Xu, Donald Seto.   

Abstract

Novel human adenoviruses (HAdVs) arise from genome recombination. Analysis of HAdV type 55 from an outbreak in China shows a hexon recombination between HAdV-B11 and HAdV-B14, resulting in a genome that is 97.4% HAdV-B14. Sporadic appearances as a re-emergent pathogen and misidentification as "HAdV-B11a" are due to this partial hexon.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20042633      PMCID： PMC2832463          DOI： 10.1128/JCM.01694-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  22 in total

1.  Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture.

Authors:  W P ROWE; R J HUEBNER; L K GILMORE; R H PARROTT; T G WARD
Journal:  Proc Soc Exp Biol Med       Date:  1953-12

2.  UCSF Chimera--a visualization system for exploratory research and analysis.

Authors:  Eric F Pettersen; Thomas D Goddard; Conrad C Huang; Gregory S Couch; Daniel M Greenblatt; Elaine C Meng; Thomas E Ferrin
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

3.  MAVID: constrained ancestral alignment of multiple sequences.

Authors:  Nicolas Bray; Lior Pachter
Journal:  Genome Res       Date:  2004-04       Impact factor: 9.043

4.  zPicture: dynamic alignment and visualization tool for analyzing conservation profiles.

Authors:  Ivan Ovcharenko; Gabriela G Loots; Ross C Hardison; Webb Miller; Lisa Stubbs
Journal:  Genome Res       Date:  2004-03       Impact factor: 9.043

5.  Occurrence of respiratory illness due to an atypical strain of adenovirus type 11 during a large outbreak in Spanish military recruits.

Authors:  J C Hierholzer; A Pumarola; A Rodriguez-Torres; M Beltran
Journal:  Am J Epidemiol       Date:  1974-06       Impact factor: 4.897

6.  Acute hemorrhagic cystitis in children. Isolation of adenovirus type II.

Authors:  Y Numazaki; S Shigeta; T Kumasaka; T Miyazawa; M Yamanaka; N Yano; S Takai; N Ishida
Journal:  N Engl J Med       Date:  1968-03-28       Impact factor: 91.245

7.  Antigenic characterization of intermediate adenovirus 14-11 strains associated with upper respiratory illness in a military camp.

Authors:  J C Hierholzer; A Pumarola
Journal:  Infect Immun       Date:  1976-02       Impact factor: 3.441

8.  Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination.

Authors:  K S Lole; R C Bollinger; R S Paranjape; D Gadkari; S S Kulkarni; N G Novak; R Ingersoll; H W Sheppard; S C Ray
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

9.  Genetic relationship between thirteen genome types of adenovirus 11, 34, and 35 with different tropisms.

Authors:  Q G Li; J Hambraeus; G Wadell
Journal:  Intervirology       Date:  1991       Impact factor: 1.763

10.  Analysis of 15 adenovirus hexon proteins reveals the location and structure of seven hypervariable regions containing serotype-specific residues.

Authors:  L Crawford-Miksza; D P Schnurr
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103
View more
  111 in total

1.  Comparison of in-house real-time quantitative PCR to the Adenovirus R-Gene kit for determination of adenovirus load in clinical samples.

Authors:  Hélène Jeulin; Alexandra Salmon; Pierre Bordigoni; Véronique Venard
Journal:  J Clin Microbiol       Date:  2010-07-14       Impact factor: 5.948

2.  Overreliance on the hexon gene, leading to misclassification of human adenoviruses.

Authors:  Gurdeep Singh; Christopher M Robinson; Shoaleh Dehghan; Timothy Schmidt; Donald Seto; Morris S Jones; David W Dyer; James Chodosh
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

Review 3.  Genomic foundations of evolution and ocular pathogenesis in human adenovirus species D.

Authors:  Ashrafali Mohamed Ismail; Xiaohong Zhou; David W Dyer; Donald Seto; Jaya Rajaiya; James Chodosh
Journal:  FEBS Lett       Date:  2019-12-11       Impact factor: 4.124

Review 4.  Getting genetic access to natural adenovirus genomes to explore vector diversity.

Authors:  Wenli Zhang; Anja Ehrhardt
Journal:  Virus Genes       Date:  2017-07-15       Impact factor: 2.332

5.  Homologous recombination in E3 genes of human adenovirus species D.

Authors:  Gurdeep Singh; Christopher M Robinson; Shoaleh Dehghan; Morris S Jones; David W Dyer; Donald Seto; James Chodosh
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

6.  Simian adenovirus type 35 has a recombinant genome comprising human and simian adenovirus sequences, which predicts its potential emergence as a human respiratory pathogen.

Authors:  Shoaleh Dehghan; Jason Seto; Morris S Jones; David W Dyer; James Chodosh; Donald Seto
Journal:  Virology       Date:  2013-10-08       Impact factor: 3.616

Review 7.  Adenovirus infections in immunocompetent and immunocompromised patients.

Authors:  Thomas Lion
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

8.  Febrile Respiratory Illness Associated with Human Adenovirus Type 55 in South Korea Military, 2014-2016

Authors:  Hongseok Yoo; Se Hun Gu; Jaehun Jung; Dong Hyun Song; Changgyo Yoon; Duck Jin Hong; Eun Young Lee; Woong Seog; Il-Ung Hwang; Daesang Lee; Seong Tae Jeong; Kyungmin Huh
Journal:  Emerg Infect Dis       Date:  2017-06       Impact factor: 6.883

9.  Quantitative real-time PCR assay panel for detection and type-specific identification of epidemic respiratory human adenoviruses.

Authors:  Xiaoyan Lu; Elizabeth Trujillo-Lopez; Lisa Lott; Dean D Erdman
Journal:  J Clin Microbiol       Date:  2013-01-16       Impact factor: 5.948

10.  Insight into the mechanisms of adenovirus capsid disassembly from studies of defensin neutralization.

Authors:  Jason G Smith; Mariena Silvestry; Steffen Lindert; Wuyuan Lu; Glen R Nemerow; Phoebe L Stewart
Journal:  PLoS Pathog       Date:  2010-06-24       Impact factor: 6.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.